Two weeks ago, Mexico celebrated its Global Rare Diseases Week 2015, to put the spotlight on orphan diseases in Latin and South America. In honor of this week, several international meetings were organized in association with the Mexican associations of rare diseases FEMEXER and GEISER, highlighting developments in the rare disease and orphan drug field. The week started with the 4th Latin American meeting of Rare Diseases on October 12, followed by the Discoveries and Innovations in Orphan Drugs Congress on October 13-14 and ended with the 10th International Conference on Rare Diseases & Orphan Drugs (ICORD 2015) on October 15-16.
At the occasion of the Discoveries and Innovation in Orphan Drugs Congress, Dr Ségolène Aymé, coordinator of the scientific secretariat IRDiRC, gave an overview presentation of the perspective of IRDiRC on the trends and opportunities in the field of orphan drugs research and development. The audience was reminded to look at the essential and long term common interest at stake across patients, companies, competent authorities, rather than antagonizing the short term and short take of diverging interest. IRDiRC was also briefly presented at the ICORD conference, in which the achievements so far were set out. The presentation was concluded by a future perspective focusing on the different IRDiRC Task Forces.